Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-Amodiaquine vs Artemether-Lumefantrine in Children with Malaria
NCT04565184Phase 4Completed
- Sponsor
- University of Yaoundé I
- Start
- May 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate + amodiaquine, artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by University of Yaoundé I. Started May 2019; status: completed.
02
Drugs
artesunate + amodiaquineartemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT04565184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04565184.